This observation is particularly significant in light of recent clinical data linking TREM2-agonist antibodies to increased vascular damage and ARIA in Alzheimer's disease (AD) patients [10], suggesting a potential role for TREM2 in regulating microhemorrhages and ARIA. The gene discussed is TREM2; the disease is early-onset autosomal dominant Alzheimer disease.